JP Patent

JP6836988B2 — Ｈａｏ１（ヒドロキシ酸オキシダーゼ１（グリコール酸オキシダーゼ））遺伝子の発現の阻害のための組成物および方法

Assigned to Alnylam Pharmaceuticals Inc · Expires 2021-03-03 · 5y expired

What this patent protects

Patent listed against lumasiran-sodium.

Drugs covered by this patent

Patent Metadata

Patent number
JP6836988B2
Jurisdiction
JP
Classification
—
Expires
2021-03-03
Drug substance claim
No
Drug product claim
No
Assignee
Alnylam Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.